Skip to main content

Table 1 Distribution of Demographics Grouped by 25(OH)D Quartile

From: Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer

 

Vitamin D Quartile

<20 ng/mL

20–39 ng/mL

40–59 ng/mL

60 + ng/mL

Total

25(OH)D

 

Characteristic

No. patients (%)

No. patients (%)

No. patients (%)

No. patients (%)

No. patients (%)

Avg. ng/mL (SD)

P-value

Gender

       

 Male

105 (56)

167 (56)

63 (52)

7 (32)

342 (55)

28 (±14)

0.15

 Female

83 (44)

129 (44)

58 (48)

15 (68)

285 (45)

30 (±17)

Ethnicity

      

<0.0001

 Caucasian

118 (25)

236 (50)

106 (22)

16 (3)

476 (76)

31 (±15)

 African American

57 (53)

36 (34)

11 (10)

3 (3)

107 (17)

22 (±15)

 Hispanic

0 (0)

7 (44)

0 (0)

1 (6)

16 (3)

22 (±14)

 Asian

0 (0)

4 (100)

0 (0)

0 (0)

4 (0.6)

30 (±6)

 Polynesian

0 (0)

0 (0)

1 (100)

0 (0)

1 (0.2)

48 (±0)

 Other*

5 (22)

5 (22)

3 (13)

2 (9)

23 (4)

30 (±16)

Cancer Stage

      

0.36

 1B

4 (50)

2 (25)

2 (25)

0 (0)

8 (1)

23 (±14)

 2A

13 (48)

9 (33)

4 (4)

1 (4)

27 (4)

24 (±16)

 2B

15 (31)

27 (56)

3 (6)

3 (6)

48 (8)

27 (±14)

 3

24 (28)

40 (47)

19 (22)

3 (3)

86 (14)

30 (±15)

 4

131(29)

216 (48)

92 (20)

15 (3)

454 (72)

29 (±16)

 Non-staged

1 (25)

2 (50)

1 (25)

0 (0)

4 (1)

28 (±11)

BMI (kg/m2)

      

0.05

  < 18.5

7 (27)

8 (31)

9 (35)

2 (8)

26 (4)

35 (±19)

 18.5–24.9

67 (25)

126 (48)

57 (22)

14 (5)

264 (42)

31 (±17)

 25–29.9

74 (36)

98 (47)

33 (16)

2 (1)

207 (33)

26 (±13)

 30+

40 (31)

64 (49)

22 (17)

4 (3)

130 (21)

28 (±14)

  1. *Other ethnicities are patients who did not identify with any ethnicity listed above